Novartis Kymriah demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting

This article was originally published here

These analyses are from a readout of a 15-year post-marketing study that add to and complement the rigor of the Kymriah pivotal trials with evidence of the Kymriah

The post Novartis Kymriah demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply